Skip to content

ARTIA Reconstructive Tissue Matrix CS1097PRecalls & reported problems

Lifecell Corporation · ARTIA Reconstructive Tissue Matrix Perforated Contour Small · Class 2 · Implant

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI M328CS1097P0), received between May 20, 2025 and Sep 10, 2025 — classified as 3 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 2 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 1 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3

Patient problems

  • Bacterial Infection3
  • Seroma3
  • Skin Inflammation/ Irritation2

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjurySep 10, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    HEALTHCARE PROFESSIONAL REPORTED THAT A CLINICAL PATIENT THAT WAS IMPLANTED WITH ARTIA HAS EXPERIENCED INFECTED SEROMA IN THE LEFT BREAST. THE FOLLOWING ACTIONS HAVE BEEN TAKEN: SEROMA ASPIRATED FOR TURBID SEROMA, CULTURE SENT, AND SEROMA CATHETER PLACED. KEFLEX ORAL ANTIBIOTIC HAS BEEN GIVEN AS A TREATMENT. SYMPTOMS HAVE BEEN RESOLVED. IT WAS CONFIRMED LATER THAT BOTH LOT NUMBERS UP200128-112, AND UP200133-274 WERE USED ON THE LEFT BREAST IN THE ORIGINAL IMPLANT. THIS IS THE SAME PATIENT REPORTED UNDER PATIENT IDENTIFIER (B)(6). THIS EMDR IS BEING SUBMITTED FOR THE LOT # UP200128-112.

    Patient problems: Bacterial Infection; Seroma

    MAUDE report 23020090 ↗
  • InjuryMay 20, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON 04/21/2025, PMQA BECAME AWARE OF A CLINICAL STUDY IN THE USA REPORTING RIGHT BREAST ERYTHEMA, SWELLING AND PAIN. SITE NAME: (B)(6) SYSTEM. RELATIONSHIP TO STUDY DEVICE (ARTIA): NOT RELATED. RELATIONSHIP TO STUDY DEVICE PROCEDURE (ARTIA IMPLANTATION): NOT RELATED. PATIENT RECEIVED LEVAQUIN AND TORADOL AS PROPHYLACTIC TREATMENT. PATIENT HAS "ANXIETY AND WAS CONCERNED THAT THE SWELLING IN BREAST HAS INCREASED SINCE FOLLOW UP THE DAY PRIOR." PATIENT "WENT TO THE ER THE FOLLOWING DAY WITH CONCERNS OF WORSENING CONDITIONS. ER GAVE [THEM] MEDICATION TO HELP WITH DISCOMFORT UNTIL NEXT FOLLOW UP, BUT NO NEW SYMPTOMS WERE NOTED." THIS RECORD REPRESENTS 2 OUT OF 2 ARTIA PIECES (RELATED COMPLAINT NUMBER: (B)(6). ARTIA WAS REMOVED. "ARTIA HAD NOT ADHERED TO PATIENT AT ALL AND SEROMA WAS HEAVILY INFECTED. PI MADE THE DECISION TO REMOVE DEVICE ENTIRELY. SAE AND PROCEDURE DOCUMENTED. SHE HAS ANTIBIOTICS NOW." "PATIENT HAD ERYTHEMA AND DRAINAGE WHICH TESTED POSITIVE FOR KLEBSIELLA. CONDITIONS WORSENED FROM PREVIOUS AE." RELATIONSHIP TO ARTIA IS LISTED AS 'POSSIBLE.' ORGANISMS IDENTIFIED: KLEBSIELLA AEROGENES AND FINEGOLDIA MAGNA ON (B)(6) 2025. "INITIALLY WAS BREAST IRRIGATION WITH DEBRIDEMENT W

    Patient problems: Bacterial Infection; Seroma; Skin Inflammation/ Irritation

    MAUDE report 22054597 ↗
  • InjuryMay 20, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON 04/21/2025, PMQA BECAME AWARE OF A CLINICAL STUDY IN THE USA REPORTING RIGHT BREAST ERYTHEMA, SWELLING AND PAIN. RELATIONSHIP TO STUDY DEVICE (ARTIA): NOT RELATED. RELATIONSHIP TO STUDY DEVICE PROCEDURE (ARTIA IMPLANTATION): NOT RELATED. PATIENT RECEIVED LEVAQUIN AND TORADOL AS PROPHYLACTIC TREATMENT. PATIENT HAS "ANXIETY AND WAS CONCERNED THAT THE SWELLING IN BREAST HAS INCREASED SINCE FOLLOW UP THE DAY PRIOR." PATIENT "WENT TO THE ER THE FOLLOWING DAY WITH CONCERNS OF WORSENING CONDITIONS. ER GAVE [THEM] MEDICATION TO HELP WITH DISCOMFORT UNTIL NEXT FOLLOW UP, BUT NO NEW SYMPTOMS WERE NOTED." THIS RECORD REPRESENTS 1 OUT OF 2 ARTIA PIECES (RELATED COMPLAINT NUMBER CN-253258). ARTIA WAS REMOVED. "ARTIA HAD NOT ADHERED TO PATIENT AT ALL AND SEROMA WAS HEAVILY INFECTED. PI MADE THE DECISION TO REMOVE DEVICE ENTIRELY. SAE AND PROCEDURE DOCUMENTED. SHE HAS ANTIBIOTICS NOW." "PATIENT HAD ERYTHEMA AND DRAINAGE WHICH TESTED POSITIVE FOR KLEBSIELLA. CONDITIONS WORSENED FROM PREVIOUS AE." RELATIONSHIP TO ARTIA IS LISTED AS 'POSSIBLE.' ORGANISMS IDENTIFIED: KLEBSIELLA AEROGENES AND FINEGOLDIA MAGNA ON (B)(6) 2025. "INITIALLY WAS BREAST IRRIGATION WITH DEBRIDEMENT WHICH BECAME A FULL DEVI

    Patient problems: Bacterial Infection; Seroma; Skin Inflammation/ Irritation

    MAUDE report 22054450 ↗

Other Mesh, Surgical devices

All Mesh, Surgical devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.